Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Boston Scientific (BSX) stocks in Canada
Learn how to easily invest in Boston Scientific stocks.
Boston Scientific is a medical devices business based in the US. Boston Scientific stocks (BSX.US) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $48.33 – a decrease of 1.04% over the previous week. Boston Scientific employs 45,000 staff and has a trailing 12-month revenue of around $12.7 billion.
How to buy Boston Scientific stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – BSX. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
CIBC Investor's Edge
- Easy to use platform
- Low fees
- Student and young investor discounts
- Access to international stock exchanges
- Low margin rates
- Powerful research tools
National Bank Direct Brokerage
- Commission-free trading
- Several account types available
- Access to array of research tools
What's in this guide?
- Can I buy shares in Boston Scientific?
- Has coronavirus impacted Boston Scientific shares?
- Boston Scientific shares summary
- Compare share dealing platforms
- Is Boston Scientific stock a buy or sell?
- Boston Scientific performance over time
- Is Boston Scientific suitable for ethical investing?
- Are Boston Scientific shares over-valued?
- Boston Scientific's financials
- How volatile are Boston Scientific shares?
- Does Boston Scientific pay a dividend?
- Have Boston Scientific shares ever split?
- Other common questions
Boston Scientific stock price (NYSE:BSX)Use our graph to track the performance of BSX stocks over time.
Boston Scientific shares at a glance
|Latest market close||$48.33|
|52-week range||$34.98 - $49.22|
|50-day moving average||$46.95|
|200-day moving average||$42.69|
|Wall St. target price||$53.00|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$0.46|
Buy Boston Scientific stocks from these online trading platformsCompare special offers, low fees and a wide range of investment options among top trading platforms.
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Boston Scientific stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Boston Scientific price performance over time
Historical closes compared with the close of $48.33 from 2023-03-27
|1 week (2023-03-21)||-1.04%|
|1 month (2023-02-28)||3.45%|
|3 months (2022-12-28)||5.57%|
|6 months (2022-09-28)||23.51%|
|1 year (2022-03-25)||11.10%|
|2 years (2021-03-26)||26.45%|
|3 years (2020-03-27)||57.89%|
|5 years (2018-03-28)||81.15%|
Is Boston Scientific stock undervalued or overvalued?
Valuing Boston Scientific stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Boston Scientific's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Boston Scientific's P/E ratio
Boston Scientific's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 106x. In other words, Boston Scientific shares trade at around 106x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Boston Scientific's PEG ratio
Boston Scientific's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.5307. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Boston Scientific's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Boston Scientific's EBITDA
Boston Scientific's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $3.2 billion.
The EBITDA is a measure of a Boston Scientific's overall financial performance and is widely used to measure a its profitability.
Boston Scientific financials
|Revenue TTM||$12.7 billion|
|Operating margin TTM||16.03%|
|Gross profit TTM||$8.7 billion|
|Return on assets TTM||3.93%|
|Return on equity TTM||4.08%|
|Market capitalisation||$70.1 billion|
TTM: trailing 12 months
Boston Scientific's environmental, social and governance track record
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Boston Scientific.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Boston Scientific's total ESG risk score
Total ESG risk: 29.23
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Boston Scientific's overall score of 29.23 (as at 01/01/2019) is nothing to write home about – landing it in it in the 57th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Boston Scientific is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Boston Scientific's environmental score
Environmental score: 1.51/100
Boston Scientific's social score
Social score: 12.87/100
Boston Scientific's governance score
Governance score: 7.87/100
Boston Scientific's controversy score
Controversy score: 3/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Boston Scientific scored a 3 out of 5 for controversy – a middle-of-the-table result reflecting that Boston Scientific hasn't always managed to keep its nose clean.
Boston Scientific share dividends
We're not expecting Boston Scientific to pay a dividend over the next 12 months.
Have Boston Scientific's shares ever split?
Boston Scientific's shares were split on a 2:1 basis on 6 November 2003. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Boston Scientific shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Boston Scientific shares which in turn could have impacted Boston Scientific's share price.
Boston Scientific share price volatility
Over the last 12 months, Boston Scientific's shares have ranged in value from as little as $34.98 up to $49.22. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Boston Scientific's is 0.7853. This would suggest that Boston Scientific's shares are less volatile than average (for this exchange).
Boston Scientific overview
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through MedSurg and Cardiovascular segments. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, that uses in the treatment of coronary artery disease and aortic valve conditions. Further, it provides stents, balloon catheters, guidewires, atherectomy, and thrombectomy systems to treat arterial and venous diseases; and peripheral embolization devices, radioactive microspheres, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
Stocks similar to Boston Scientific
Boston Scientific in the news
Boston Scientific (NYSE:BSX) shareholders have earned a 12% CAGR over the last five years
Boston Scientific's Wicked Rally Can Take the Stock 20% Higher
Here's Why You Should Retain Boston Scientific (BSX) Now
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More on investing
How do ETFs work?
Your guide to how ETFs work and whether this type of investment is right for you.Read more…
Best stock app for beginners
The best stock trading app for beginners is easy to use and offers free trades.Read more…
How to read stock charts
Learning how to read stock charts and recognize chart patterns can unlock your success as a trader.Read more…
More guides on Finder
How to buy Neuraxis (NRXS) stock in Canada when it goes public
Everything we know about the Neuraxis IPO plus information on how to buy in.
How to buy Brera (BREA) stock in Canada
Everything we know about the Brera IPO plus information on how to buy in.
How to buy TXO Energy (TXO) stock in Canada
Everything we know about the TXO Energy IPO plus information on how to buy in.
How do ETFs work?
Your guide to how ETFs work and whether this type of investment is right for you.
How to buy Torex Gold stock in Canada
Steps to owning and managing TXG stock, with 24-hour and historical pricing before you buy.
Best stock app for beginners
The best stock trading app for beginners is easy to use and offers free trades.
How to read stock charts
Learning how to read stock charts and recognize chart patterns can unlock your success as a trader.
3 upcoming IPOs to watch in March 2023
An healthcare company, NFT tech developer and baby products retailer are among the IPOs expected to take place this month.
What are stocks?
Owning a stock means you own part of a company and can potentially grow your wealth. But there is a risk of loss.
Best time to buy stocks
The best time to buy stocks could be right after an IPO, during expansion periods or when other investors are buying or selling.